No profile data available.
OnKure Therapeutics, Inc. (OKUR) is a healthcare company in the additional cancer treatment drugs industry, based in Boulder, United States, with about 45 full-time employees.
It reported revenue of $0 for fiscal year 2024, and net income of -$52.67 million. In Q3 2025 (the quarter ended September 30, 2025) revenue was $0. Its market capitalization was $97.35 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
, a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases.
OnKure Therapeutics reported $0 in revenue for fiscal year 2024. In Q3 2025 revenue was $0.
$97.35 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional cancer treatment drugs) include Corbus Pharmaceuticals Holdings, Inc. (CRBP), Anixa Biosciences, Inc. (ANIX), PDS Biotechnology Corporation (PDSB), Context Therapeutics Inc. (CNTX).